Potential of E-Cigarettes to Improve Public Health: Expert Opinion

Sep.19.2022
Potential of E-Cigarettes to Improve Public Health: Expert Opinion
Tikki Pangestu believes e-cigarettes have potential to improve public health, citing data from independent UK studies.

Tikki Pangestu, a former director of policy research and cooperation at the World Health Organization, discussed the potential of e-cigarettes to improve public health. Professor Pangestu made a positive statement during an online discussion titled "Reducing Smoking Harm: Is it Possible to Reduce Tobacco Harm?


Professor Tikki Pang is currently a visiting professor at the Yong Loo Lin School of Medicine at the National University of Singapore. Prior to serving as Director of the World Health Organization, he was a professor at the Lee Kuan Yew School of Public Policy and a biomedical professor at the University of Malaya.


In his academic career spanning 30 years, Professor Peng has published over 250 scientific articles and 12 books covering topics such as epidemiology, pathogenesis, laboratory diagnosis, prevention of infectious diseases, biosafety, and dual-use research. He is recognized as an expert in public health both domestically and internationally.


According to Tikki Pang, there are still nearly 70 million smokers in his country, which has resulted in economic costs for the nation and significant socioeconomic burden for individuals.


He said, "From a public health and socio-economic perspective, this issue requires a strategic intervention and policy to reduce smoking rates in Indonesia.


Compared to products such as nicotine replacement therapy, interventions using products that promote harm reduction concepts are more effective for those who wish to quit smoking. This is a key strategy in addressing this highly complex issue. The products that result from technological advances and innovation have enormous potential.


Professor Peng cites facts and data from independent research in the UK to urge Indonesian lawmakers to accept electronic cigarettes, snus, and heated tobacco products.


The road to a healthier nation depends on the government ensuring that adult smokers have easy access to lesser harmful new nicotine products and that the information provided is accurate and truthful.


British cancer expert Peter Harper agrees with this. He commented, "You smoke to satisfy your need for nicotine, but you die from smoking. Quitting smoking immediately is one solution. However, current strategies are not effective. Innovative products provide solutions for those struggling to quit, while reducing the overall impact on well-being.


Statement:


This article is compiled from third-party information and is intended solely for communication and learning within the industry.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in our translation abilities, the translated article may not perfectly reflect the original text. Please refer to the original article for accuracy.


2FIRSTS holds the same views and positions as the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and stances.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
Multi-State Coalition Urges F1 to End Nicotine Sponsorships, Citing Zyn and Velo
Multi-State Coalition Urges F1 to End Nicotine Sponsorships, Citing Zyn and Velo
Hawaii Attorney General Anne Lopez is co-leading a coalition of 19 states and jurisdictions urging the Fédération Internationale de l’Automobile (FIA) and Formula 1 to end sponsorships involving tobacco and nicotine products, including nicotine pouch brands such as Zyn and Velo.
News
Jun.09
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25
RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
The Texas Supreme Court issued a case summary on May 8, 2026, describing its decision in Hancock v. RJR Vapor Co. LLC. The dispute centered on whether RJR Vapor’s VELO oral nicotine pouches are taxable as “tobacco products” under the Texas Tax Code. Lower courts had held that the pouches were not taxable tobacco products, but the Texas Supreme Court reversed, concluding that VELO pouches are taxable because they are made of “a tobacco substitute.”
May.09 by 2FIRSTS.ai
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05